Yahoo Web Search

Search results

    • TIME100 Health: David Ricks

      TIME100 Health: David Ricks

      Time via Yahoo Finance· 4 hours ago

      The U.S. Food and Drug Administration (FDA) approved Lilly’s tirzepatide, marketed as Mounjaro for diabetes, in 2022, and Zepbound...

    • Peter Marks

      Peter Marks

      Time Magazine· 4 hours ago

      In 2023, the U.S. Food and Drug Administration (FDA) brought a number of never-before-seen treatments to market, approving the first ...